Your browser doesn't support javascript.
loading
A research agenda for curing chronic hepatitis B virus infection.
Alter, Harvey; Block, Timothy; Brown, Nathaniel; Brownstein, Alan; Brosgart, Carol; Chang, Kyong-Mi; Chen, Pei-Jer; Chisari, Francis V; Cohen, Chari; El-Serag, Hashem; Feld, Jordan; Gish, Robert; Glenn, Jeffrey; Greten, Tim; Guo, Haitao; Guo, Ju-Tao; Hoshida, Yujin; Hu, Jianming; Kowdley, Kris V; Li, Wenhui; Liang, Jake; Locarnini, Stephan; Lok, Anna S; Mason, William; McMahon, Brian; Mehta, Anand; Perrillo, Robert; Revill, Peter; Rice, Charles M; Rinaudo, JoAnn; Schinazi, Raymond; Seeger, Christoph; Shetty, Kirty; Tavis, John; Zoulim, Fabien.
Afiliação
  • Alter H; Clinical Center, National Institutes of Health, Bethesda, MD.
  • Block T; Hepatitis B Foundation and Baruch S. Blumberg Institute, Doylestown, PA.
  • Brown N; Hepatitis B Foundation and Baruch S. Blumberg Institute, Doylestown, PA.
  • Brownstein A; Hepatitis B Foundation and Baruch S. Blumberg Institute, Doylestown, PA.
  • Brosgart C; University of California San Francisco School of Medicine, San Francisco, and University of California at Berkeley School of Public Health, National Viral Hepatitis Roundtable, Berkeley, CA.
  • Chang KM; University of Pennsylvania School of Medicine and the Philadelphia Veterans Hospital, Philadelphia, PA.
  • Chen PJ; National Taiwan University, Taipei, Taiwan.
  • Chisari FV; Scripps Institute, La Jolla, CA.
  • Cohen C; Hepatitis B Foundation and Baruch S. Blumberg Institute, Doylestown, PA.
  • El-Serag H; Baylor College of Medicine, Houston, TX.
  • Feld J; Toronto General Hospital, Toronto, Canada.
  • Gish R; Hepatitis B Foundation and Baruch S. Blumberg Institute, Doylestown, PA.
  • Glenn J; Stanford University Medical Center, Palo Alto, CA.
  • Greten T; Stanford University School of Medicine, Palo Alto, CA.
  • Guo H; National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Guo JT; Indiana University School of Medicine, Indianapolis, IN.
  • Hoshida Y; Hepatitis B Foundation and Baruch S. Blumberg Institute, Doylestown, PA.
  • Hu J; Mt. Sinai School of Medicine, New York, NY.
  • Kowdley KV; Pennsylvania State University College of Medicine, Hershey, PA.
  • Li W; Swedish Medical Center, Seattle, WA.
  • Liang J; National Institute of Biological Sciences, Beijing, China.
  • Locarnini S; National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
  • Lok AS; Victorian Infectious Diseases Laboratories, Melbourne, Australia.
  • Mason W; University of Michigan School of Medicine, Ann Arbor, MI.
  • McMahon B; Fox Chase Cancer Center, Philadelphia, PA.
  • Mehta A; Alaska Native Medical Center, Anchorage, AK.
  • Perrillo R; Medical University of South Carolina, Charleston, SC.
  • Revill P; Baylor University Medical Center, Dallas, TX.
  • Rice CM; Victorian Infectious Diseases Laboratories, Melbourne, Australia.
  • Rinaudo J; Rockefeller University, New York, NY.
  • Schinazi R; National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Seeger C; Emory University, Atlanta, GA.
  • Shetty K; Fox Chase Cancer Center, Philadelphia, PA.
  • Tavis J; Johns Hopkins University, Baltimore, MD.
  • Zoulim F; St. Louis School of Medicine, St. Louis, MO.
Hepatology ; 67(3): 1127-1131, 2018 03.
Article em En | MEDLINE | ID: mdl-28877549
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Hepatite B / Hepatite B Crônica Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Hepatite B / Hepatite B Crônica Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article